Novartis

Glaxo’s Best ‘Headache’ Remedy May Be Buying Stakes in Ventures
Bloomberg
Fri, 08/7/15 - 08:44 am
GSK
Advair
Pfizer
Shionogi
Novartis
FDA updates label for Novartis' MS pill Gilenya after reports of brain infection
Fierce Pharma
Wed, 08/5/15 - 02:46 pm
FDA
Novartis
Gilenya
MS
multiple sclerosis
Will Biogen Win From Novartis MS Drug Safety Label Change?
Yahoo/24 7 Wall St
Tue, 08/4/15 - 06:54 pm
Biogen
Novartis
MS
multiple sclerosis
Gilenya
Why Sandoz Revenues Were Important for Novartis in 2Q15
Yahoo/Market Realist
Wed, 07/29/15 - 12:43 pm
Novartis
Sandoz
generics
earnings
Novartis swaps mid-stage compounds for equity stake in start-up Mereo BioPharma
First Word Pharma
Wed, 07/29/15 - 12:42 pm
Novartis
Mereo BioPharma
Sandoz closing three German and Indian factories
BioPharma Dive
Tue, 07/28/15 - 10:14 am
Sandoz
Novartis
generics
Germany
India
Analyst: J&J's Stelara to challenge Novartis in ankylosing spondylitis
Fierce Pharma
Tue, 07/28/15 - 12:36 am
JNJ
Stelara
Novartis
ankylosing spondylitis
FDA OK's Odomzo from Novartis for common skin cancer type
Yahoo/AP
Sat, 07/25/15 - 09:41 am
FDA
Odomzo
Novartis
basal cell carcinoma
skin cancer
Novartis melanoma drug combination wins EU green light
Yahoo/Reuters
Sat, 07/25/15 - 09:38 am
Novartis
melanoma
Europe
Mekinist
Tafinlar
GSK
J&J's Stelara may be under fire in psoriasis, but it's positioned to score elsewhere
Fierce Pharma Marketing
Fri, 07/24/15 - 05:59 pm
JNJ
Stelara
psoriasis
Novartis
Cosentyx
Novartis whacks 3 Sandoz plants, 770 jobs, despite generic units' sales growth
Fierce Pharma
Thu, 07/23/15 - 11:30 pm
Novartis
Sandoz
generics
drug manufacturing
Novartis bullish on Afinitor cancer drug despite new competition
Yahoo/Reuters
Tue, 07/21/15 - 06:52 pm
Novartis
Afinitor
Opdivo
Cometriq
Exelixis
Bristol-Myers Squibb
Novartis blocked from selling Neupogen copycat until Sept. 2
Yahoo/Reuters
Tue, 07/21/15 - 12:47 pm
Novartis
biosimilars
Neupogen
Zarxio
Sandoz
Amgen
Novartis looks past dim Q2 results to new Glatopa, Entresto launches
Fierce Pharma
Tue, 07/21/15 - 10:28 am
Novartis
earnings
drug launches
Glatopa
Entresto
Novartis confirms 2015 outlook after Q2 profit miss
CNBC
Tue, 07/21/15 - 09:57 am
Novartis
earnings
WHO prequalifies Novartis' Coartem for malaria
BioPharma Dive
Mon, 07/20/15 - 11:04 am
Novartis
malaria
Coartem
WHO
Top 10 pharma companies in social media
Fierce Pharma Marketing
Mon, 07/20/15 - 09:12 am
social media
Boehringer Ingelheim
Bayer
Novartis
JNJ
Merck
Abbott Labs
GSK
Roche
Novo Nordisk
AstraZeneca
6 Big-Cap Drugmakers Reporting Earnings Next Week
Investors.com
Sat, 07/18/15 - 11:00 am
earnings
Novartis
Bristol-Myers Squibb
Eli Lilly
Valeant Pharmaceuticals
AbbVie
Biogen
Novartis off to scorching start with Copaxone generic Glatopa
Fierce Pharma Marketing
Mon, 07/13/15 - 11:11 am
Novartis
Copaxone
generics
Glatopa
MS
multiple scleroiss
Momenta
Sandoz
For Entresto rollout, Novartis marketing mixes tried-and-true with new-and-different
Fierce Pharma Marketing
Mon, 07/13/15 - 11:09 am
Novartis
Entresto
drug launches

Pages